Related Experiment Video
Updated: Aug 17, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Knowledge of hepatitis among active drug injectors at a syringe exchange program
Jeanne Carey1, David C Perlman, Patricia Friedmann
1Department of Medicine, Beth Israel Medical Center, New York, NY 10003, USA. jcarey@bethisraelny.org
Abstract:
Injecting drug users (IDUs) are at high risk for contracting and spreading viral hepatitis through nonsterile injection practices, unprotected sexual contact, and unsanitary living conditions. We sought to characterize hepatitis knowledge, prior testing, and vaccination history among IDUs at a New York City syringe exchange program (SEP). IDU subjects generally had a poor understanding of viral hepatitis transmission and prevention. We also found low vaccination rates: only 8% reported receiving hepatitis A vaccine and 11%, hepatitis B vaccine. Educating IDUs about risky behaviors and medical preventive interventions, such as vaccines for hepatitis A and B and treatment for hepatitis C, may help prevent disease and reduce transmission. Stronger linkages between health-care centers and SEPs, drug treatment programs, and other service delivery centers where IDUs are encountered may promote hepatitis education and vaccination.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Prevention of Further Absorption of Poison
Drug Elimination: Non-Renal Routes
